Hennion & Walsh Asset Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,312
| Closed | -$942K | – | 857 |
|
|
2024
Q3 | $942K | Sell |
6,312
-663
| -10% | -$99K | 0.04% | 463 |
|
|
2024
Q2 | $951K | Sell |
6,975
-59
| -0.8% | -$8.05K | 0.05% | 435 |
|
|
2024
Q1 | $1.06M | Buy |
7,034
+882
| +14% | +$133K | 0.06% | 406 |
|
|
2023
Q4 | $775K | Sell |
6,152
-86
| -1% | -$10.8K | 0.04% | 470 |
|
|
2023
Q3 | $584K | Buy |
6,238
+448
| +8% | +$42K | 0.04% | 474 |
|
|
2023
Q2 | $517K | Buy |
5,790
+116
| +2% | +$10.4K | 0.03% | 499 |
|
|
2023
Q1 | $608K | Buy |
5,674
+964
| +20% | +$103K | 0.04% | 464 |
|
|
2022
Q4 | $575K | Buy |
+4,710
| New | +$575K | 0.04% | 469 |
|
|
2022
Q2 | – | Sell |
-12,351
| Closed | -$1.45M | – | 758 |
|
|
2022
Q1 | $1.45M | Sell |
12,351
-622
| -5% | -$73K | 0.08% | 271 |
|
|
2021
Q4 | $1.75M | Sell |
12,973
-11,545
| -47% | -$1.55M | 0.09% | 256 |
|
|
2021
Q3 | $3.91M | Sell |
24,518
-1,155
| -4% | -$184K | 0.21% | 134 |
|
|
2021
Q2 | $3.38M | Buy |
25,673
+626
| +2% | +$82.3K | 0.18% | 154 |
|
|
2021
Q1 | $3.23M | Buy |
+25,047
| New | +$3.23M | 0.19% | 142 |
|